No. 050 · Combos · Peptide Blend
Fountain of Youth
Also known as: FOY blend
- Not approved as a combo
- WADA ✗ S0, S2
Combos are blends of separate compounds, so there is no single sequence. This ring motif is decorative — open a component for its fingerprint.
Evidence
- D In vitro
- C Animal
- B Human pilot
- A RCT
- S Approved
Not ranked: combinations have no published studies of their own. See the components below.
A PubMed search found no published studies of this combination; only reviews mention it. Epitalon has only small human studies; GHK-Cu is mostly lab and skin research; the GH secretagogue is not specified.
Tiers rate the strength of published evidence — not effectiveness, safety, or a recommendation.
At a glance
- Routes studied
- Subcutaneous, Intramuscular Routes used in published research
- FDA
- Not approved as a combination
- WADA
- Prohibited · S0, S2
Overview
An anti-aging blend typically combining Epithalon, GHK-Cu, and a growth hormone secretagogue to address telomere length, skin quality, and overall vitality simultaneously.
Research status Proprietary blend; contents vary by seller; no published studies of the combination; Epithalon has only small human studies and GHK-Cu mainly lab and skin research
Mechanism
The Fountain of Youth blend is promoted as targeting three aging pathways: Epithalon, which induced telomerase in cultured human cells, GHK-Cu, which is studied for extracellular matrix remodeling and collagen synthesis, and a GH secretagogue intended to raise growth hormone. None of these combined effects has been tested in humans.
Effects reported in research
These outcomes are attributed to the individual components. The combination itself has not been studied.
- Multi-pathway anti-aging support
- Telomere and skin rejuvenation
- Improved GH-mediated recovery
- Enhanced overall vitality markers
Safety & unknowns
Individual components have documented safety profiles. Epithalon has theoretical telomerase/cancer concerns. GHK-Cu is well-tolerated. GH secretagogues carry standard GH-related risks. No combination-specific safety data. Proprietary formulations vary by provider. Not FDA-approved as a combination.
Unknowns. The combination itself has not been studied; interactions between its components are unknown.
Informational only — not medical advice. peptidemeta publishes no dosing, protocols, or sourcing. Talk to a qualified clinician about any treatment decision.
Studies [2]
- Review 2015
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Review of the GHK-Cu component, covering its proposed roles in wound healing, collagen synthesis, and skin repair.
- Preclinical 2004
Peptide promotes overcoming of the division limit in human somatic cell
Cell-culture study on the Epithalon component: treated human fetal fibroblasts showed telomere elongation and extra cell divisions.
Components
Status sources
Sources behind the tier, regulatory status, sequence and dates on this page.
- Epitalon and Epithalamin: narrative review (Int J Mol Sci 2026) pubmed.ncbi.nlm.nih.gov
- Pickart et al. 2015 — GHK and skin regeneration (review) pubmed.ncbi.nlm.nih.gov
- WADA 2026 Prohibited List — S0 (epitalon); S2.2.4 growth hormone secretagogues wada-ama.org
Cite this entry
peptidemeta. (2026). Fountain of Youth. In peptidemeta: The peptide library, ranked by evidence. Retrieved November 8, 2026, from https://peptidemeta.com/p/fountain-of-youth/
@misc{peptidemeta-fountain-of-youth,
title = {Fountain of Youth},
author = {{peptidemeta}},
year = {2026},
howpublished = {\url{https://peptidemeta.com/p/fountain-of-youth/}},
note = {Accessed 2026-11-08}
} Accessed date reflects when you opened this page. Cite primary studies for scientific claims.